Drupal.behaviors.print = function(context) {window.print();window.close();}>
Gene-Activation Firm Rana Therapeutics Closes $20.7M Series A Round
January 19, 2012
Gene-Activation Firm Rana Therapeutics Closes $20.7M Series A Round
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
RNAi Field Looks to Late-Stage Clinical Data, Approvals to Regain Pharma Interest
January 3, 2013 / Gene Silencing News
People in the News: Art Krieg, Brian Gallager, Stephen Padgette
January 19, 2012 / Gene Silencing News
UniQure, Collaborators Secure $3.2M Eurostar Grant for Huntington’s Disease Effort
May 23, 2013 / Gene Silencing News
NIH Awards $400K to Fund Three microRNA Research Grants in May
May 23, 2013 / Gene Silencing News
Alnylam Releases Proof-of-concept Data on Preclinical Porphyria Drug
May 23, 2013 / Gene Silencing News